Report Id: SNS/HC/2373 | July 2022 | Region: Global | 129 Pages
Report Scope & Overview:
The Ophthalmology PACS Market Size was esteemed at USD 143.83 million of every 2022, and is expected to arrive at USD 245.38 million by 2030, and develop at a CAGR of 6.9% over the gauge period 2023-2030.
PACS, also known as picture archiving and communication system, is a medical term used in the discipline of ophthalmology. It is largely used in healthcare organisations to digitally communicate and preserve securely electronic images and reports that are therapeutically important. The management of picture data takes place via the ophthalmology PACS, which reduces the need for manual information filing, archiving, and retrieval. A single report containing data from many modalities is made possible by the PACS system, which guarantees connection between various modalities. The ability to access all of the patient's data from a single system gives the end user another benefit. The system PACS is compact.
Age-Related Population is Growing Rapidly
Eye diseases are becoming more common
There Are Not Many Ophthalmologists
Initiatives by the Government to Promote the Adoption of EHR/EMR
Increased use of teleophthalmology
Costly Implementation and Upkeep
Emerging Markets Not Yet Used
Familiarity with EHR / EMR
Opportunities with High Growth Represented by Cloud-Based Platforms
Inadequate Compliance with Informatics Standards
IMPACT OF COVID-19
Lockdowns, travel bans, and business closures brought on by the COVID-19 have had an impact on the economies and industries of many different nations. A number of facilities and plants have been shut down, which has had a severe influence on global supply chains, product production, delivery schedules, and international sales. Few businesses have already warned of potential delivery delays and a decline in future sales of their goods. The analysis examines the COVID-19 pandemic's effects both now and in the future on the market as a whole based on the state of the market, providing more accurate and authentic estimates. Additionally, the worldwide travel restrictions put in place by nations in Europe, Asia, and North America are limiting the chances for commercial relationships and collaborations.
Separated into integrated and standalone PACS, the ophthalmology PACS market is divided. In terms of market share for ophthalmology PACS, the integrated PACS sector is anticipated to lead. Integrated PACS have benefits including simple interoperability, mobility, data security, and cost-effectiveness. They are more likely to be adopted as a result of these benefits, which is fueling this market's expansion.
By Delivery Model
On-premise and web/cloud-based platforms are the two market segments for ophthalmology PACS. In terms of market share for ophthalmology PACS, on-premise versions are anticipated to dominate. On-premise models offer greater customization options than web/cloud-based ones, which may be the cause of this.
By End User
Hospitals, specialised clinics, outpatient surgical centers, and other end users comprise the segments of the ophthalmology PACS market. In terms of market share for ophthalmology PACS, specialty clinics & ambulatory surgery centers are anticipated to lead. This end-user segment's ophthalmology PACS market is anticipated to increase as a result of the expanding patient base for the diagnosis and treatment of cataracts at specialised clinics and ASCs due to affordable therapies.
Some of the major key players are as follow: Agfa-Gevaert Group, Carl Zeiss Meditec AG, EyePACS, Heidelberg Engineering, IBM Corporation (Merge Healthcare), Canon USA Inc., VersaSuite, Medical Standard, ScImage, Topcon Corporation, Sonomed Escalon, Visbion.
By Delivery Model
By End User
Specialty Clinics & Ambulatory Surgery Centers
Other End Users
North America, then Europe, are the market's two biggest players. Age-related eye illnesses are becoming more prevalent, and this is one reason why the North American market is so dominant. Other factors influencing the use of ophthalmology PACS in this region include government initiatives toward digitization, rising EHR/EMR adoption, and growing use of data storage and sharing solutions.
Although there are many prospects for expansion in the ophthalmology sector, the substantial costs associated with these solutions' deployment and upkeep could restrict that growth.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2022||US$ 143.83 Million|
|Market Size by 2030||US$ 245.38 Million|
|CAGR||CAGR of 6.9% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Type (Integrated PACS, Standalone PACS)
• By Delivery Model (On-premise, Web/cloud-based)
• By End User (Hospitals, Specialty Clinics & Ambulatory Surgery Centers, Other End Users)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Agfa-Gevaert Group, Carl Zeiss Meditec AG, EyePACS, Heidelberg Engineering, IBM Corporation (Merge Healthcare), Canon USA Inc., VersaSuite, Medical Standard, ScImage, Topcon Corporation, Sonomed Escalon, Visbion.|
|DRIVERS||• Age-Related Population is Growing Rapidly
• Eye diseases are becoming more common
• There Are Not Many Ophthalmologists
|RESTRAINTS||• Costly Implementation and Upkeep|
Frequently Asked Questions (FAQ) :
A number of facilities and plants have been shut down, which has had a severe influence on global supply chains, product production, delivery schedules, and international sales. Few businesses have already warned of potential delivery delays and a decline in future sales of their goods.
Agfa-Gevaert Group, Carl Zeiss Meditec AG, EyePACS, Heidelberg Engineering, IBM Corporation (Merge Healthcare), Canon USA Inc. are the key players of Ophthalmology PACS market
North America, then Europe, are the market's two biggest players. Age-related eye illnesses are becoming more prevalent, and this is one reason why the North American market is so dominant.
Age-Related Population is Growing Rapidly, and Eye diseases are becoming more common are the key drivers of the Ophthalmology PACS market
Ophthalmology PACS Market Size was esteemed at USD 134.6 billion of every 2021, and expected to arrive at USD 214.8 billion by 2028.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
220.127.116.11 United Kingdom
18.104.22.168 South Korea
22.214.171.124 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Ophthalmology PACS market Segmentation, By Type
8.1 Integrated PACS
8.2 Standalone PACS
9. Ophthalmology PACS Market Segmentation, By Delivery Model
10. Ophthalmology PACS Market Segmentation, By End User
10.2 Specialty Clinics & Ambulatory Surgery Centers
10.3 Other End Users
11. Regional Analysis
11.2 North America
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4.2 South Korea
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.3 South Africa
11.6 Latin America
11.6.3 Rest of Latin America
12.1 Agfa-Gevaert Group
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 Carl Zeiss Meditec AG
12.4 Heidelberg Engineering
12.5 IBM Corporation (Merge Healthcare)
12.6 Canon USA Inc.
12.8 Medical Standard
12.10 Topcon Corporation
13.1 Competitive Benchmark
13.2 Market Share analysis
13.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.